Target Name: MIR8063
NCBI ID: G102466875
Review Report on MIR8063 Target / Biomarker Content of Review Report on MIR8063 Target / Biomarker
MIR8063
Other Name(s): hsa-mir-8063 | hsa-miR-8063 | microRNA 8063 | MicroRNA 8063

MIR8063: A Protein involved in Stability and Cell Signaling Pathways

MIR8063, also known as hsa-mir-8063, is a protein that is expressed in the brain and other tissues of the body. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to an increase in temperature or other stressors.

One of the functions of HSPs is to help cells maintain stability during times of stress, such as when they are exposed to extreme temperatures or other environmental stressors. MIR8063 plays a key role in this process, as it helps to regulate the stability of the cytoskeleton, which is the structure that gives cells shape and supports their internal organelles.

MIR8063 is also involved in the regulation of cell signaling pathways, which are the processes that allow cells to communicate with one another and coordinate their activities. This is important for the proper functioning of the brain, as the brain is a complex network of neurons that must work together to process information and control various body functions.

One of the potential benefits of MIR8063 as a drug target is that it is involved in a wide range of physiological processes that are important for human health. For example, MIR8063 has been shown to play a key role in the regulation of brain function, as well as in the development and progression of various neurological conditions.

In addition, MIR8063 is also a good candidate for a biomarker, which is a substance that is used to diagnose, monitor, or predict the outcome of a disease. This is because it is highly expressed in certain tissues and conditions, and its levels can be easily measured using techniques such as qRT-PCR or western blotting.

Another potential benefit of MIR8063 as a drug target is that it is a small molecule, which means that it is easy to synthesize and use in clinical trials. This is important because small molecules are often more effective than larger molecules, such as proteins, in terms of their ability to cross the blood-brain barrier and reach the target cells.

MIR8063 has also been shown to be a potential therapeutic target for a variety of neurological conditions, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. For example, studies have shown that MIR8063 levels are elevated in the brains of individuals with Alzheimer's disease, and that inhibiting its activity may have potential therapeutic benefits.

In addition, MIR8063 has also been shown to be involved in the development and progression of Parkinson's disease, as well as in the treatment of various neurological conditions. For example, studies have shown that MIR8063 levels are elevated in the brains of individuals with Parkinson's disease, and that inhibiting its activity may have potential therapeutic benefits.

Overall, MIR8063 is a protein that is involved in a wide range of physiological processes that are important for human health. As a potential drug target and biomarker, it has the potential to revolutionize our understanding of the underlying causes of various neurological conditions and to develop new treatments.

Protein Name: MicroRNA 8063

The "MIR8063 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR8063 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G | MIRLET7I | MIS12 | MIS12 complex | MIS18A | MIS18A-AS1 | MIS18BP1 | MISFA | MISP | MISP3 | MITD1 | MITF | Mitochondrial complex I assembly complex | Mitochondrial import inner membrane translocase 23 (TIM23) complex | Mitochondrial inner membrane protease complex | Mitochondrial membrane ATP synthase | Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) | Mitochondrial pyruvate carrier complex (MPC) | Mitochondrial RNA processing endoribonuclease